Biomet Hip Lawsuit Settlement Moves Forward with Issuance of New Order in Federal Biomet Hip Replacement Litigation, Bernstein Liebhard LLP Reports

Share Article

The Firm is representing numerous Biomet hip lawsuit clients who allegedly suffered serious complications due to the metal-on-metal design of the Biomet M2a Magnum Hip Replacement System.

Free Case Review
Our Firm is representing a number of clients who may be eligible to participate in the Biomet hip replacement settlement. We are pleased to see that this matter is moving forward.

Biomet hip lawsuits ( alleging the metal-on-metal M2a Magnum Hip Replacement System caused recipients to suffer serious and debilitating complications continue to move forward in a federal multidistrict litigation underway in U.S. District Court, Northern District of Indiana. On April 14, 2014, the Court issued a Qualified Protective Order pertaining to the plaintiffs’ selection of a Lien Resolution Administrator, and its authority to act. Among other things, the Lien Administrator is tasked with resolving health insurance claims and/or liens on behalf of plaintiffs participating in the recently announced Biomet hip replacement settlement. (In re: Biomet M2a Magnum Hip Implant Products Liability Litigation – MDL No. 2391)

“Our Firm is representing a number of clients who may be eligible to participate in the Biomet hip replacement settlement. We are pleased to see that this matter is moving forward,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm continues to offer free and confidential legal consultations to individuals who may have been injured by metal-on-metal hip implants, including the Biomet M2a Magnum Hip Replacement System.

Biomet Hip Replacement Settlement
According to court documents, more than 1,600 Biomet hip lawsuits are now pending in the Northern District of Indiana, all of which allege that the meta-on-metal design of the M2a Magnum hip caused plaintiffs to suffer serious and debilitating complications, including chronic pain, metallosis, and premature device failure.

The Biomet hip replacement settlement proposal was announced in the Northern District of Indiana on February 3, 2014, and according to court documents could ultimately resolve hundreds of claims involving the M2a Magnum hip. Under the terms of the settlement, plaintiffs who received one of the affected Biomet hip replacements as part of an initial surgery that was rectified more than 180 days after it was implanted would eligible for a base award of $200,000.

To participate in the settlement program, plaintiffs must have filed their Biomet hip lawsuits no later than April 15, 2014. However, according to report from the Journal Gazette, Biomet hip recipients who did not file by that deadline may still be able to pursue individual claims against Biomet. Biomet has reserved the right to opt out of the settlement agreement if fewer than 90% of those eligible to participate refuse to do so.*

According to a safety communication issued by the U.S. Food & Drug Administration (FDA) in January 2013, metal-on-metal hip implants, which consist of a chromium/cobalt acetabular ball and femoral cup, may be more vulnerable to early failure compared to devices made from other materials. The agency has advised patients fitted with all-metal hip implants to undergo metal ion blood testing if they experience pain, swelling, or other symptoms that could be an indication that their hip is failing.

Individuals who suffered painful and debilitating complications allegedly due to a metal-on-metal hip such as Biomet M2a Magnum may be entitled to compensation for their injury-related damages. Find out more about the litigation involving Biomet hip replacements and other metal-on-metal hip implants by visiting Bernstein Liebhard LLP’s website. To arrange for a free case review, call 800-511-5092 to speak with a member of our legal staff.

*, Journal Gazette, February 7, 2014

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since the list was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Felecia L. Stern
Visit website